Recursion Pharmaceuticals Inc logo

Recursion Pharmaceuticals Inc

$ 9.40 +0.55 (+6.21%) 08:08 PM EST
P/E:
At Loss
P/B:
4.22
Market Cap:
$ 1.78B
Enterprise V:
$ 1.45B
Volume:
2.31M
Avg Vol (2M):
1.05M
Volume:
2.31M
Market Cap $:
1.78B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.05M
Enterprise Value $:
1.45B
PB Ratio:
4.22
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Name Current Vs Industry Vs History
Cash-To-Debt 8.71
Equity-to-Asset 0.64
Debt-to-Equity 0.13
Debt-to-EBITDA -0.22
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.67
Distress
Grey
Safe
Beneish M-Score -2.41
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 48.77
9-Day RSI 44.29
14-Day RSI 44.29
6-1 Month Momentum % 72.39
12-1 Month Momentum % -44.82

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.8
Quick Ratio 5.8
Cash Ratio 5.48
Days Sales Outstanding 0.44
Days Payable 39.73

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2023-03-23 Est.)

RXRX's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:RXRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 28.505
EPS (TTM) ($) -1.44
Beta 0
Volatility % 66.71
14-Day RSI 44.29
14-Day ATR ($) 0.92019
20-Day SMA ($) 10.146
12-1 Month Momentum % -44.82
52-Week Range ($) 4.92 - 21.1894
Shares Outstanding (Mil) 189.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Recursion Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Recursion Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.